[HTML][HTML] Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial

EJA Schepens, EE Blijleven, WM Boek, S Boesveldt… - BMC medicine, 2022 - Springer
Background Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …

[HTML][HTML] Short-term efficacy and safety of oral and nasal corticosteroids in COVID-19 patients with olfactory dysfunction: a European multicenter study

S Saussez, LA Vaira, CM Chiesa-Estomba, SD Le Bon… - Pathogens, 2021 - mdpi.com
Background: The objective of this study was to investigate the efficacy and safety of early
administration of oral corticosteroids (OC) or nasal corticosteroids (NC) as an add-on to …

Efficacy of topical steroids for the treatment of olfactory disorders caused by COVID‐19: a systematic review and meta‐analysis

DH Kim, SW Kim, M Kang, SH Hwang - Clinical Otolaryngology, 2022 - Wiley Online Library
Objectives The aim of this study was to assess the effect of topical steroids on acute‐onset
olfactory dysfunction in patients infected with COVID‐19. Design and Setting Systematic …

A multicenter real‐life study to determine the efficacy of corticosteroids and olfactory training in improving persistent COVID‐19‐related olfactory dysfunction

AL Pendolino, G Ottaviano, J Nijim… - Laryngoscope …, 2023 - Wiley Online Library
Background No definitive treatment exists to effectively restore function in patients with
persistent post‐infectious olfactory dysfunction (OD). Corticosteroids have been considered …

[HTML][HTML] Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell

SD Le Bon, D Konopnicki, N Pisarski, L Prunier… - European Archives of …, 2021 - Springer
Purpose As the COVID-19 pandemic continues, an increasing number of patients are
afflicted by olfactory loss, a now well-recognized symptom of the disease. Though many …

Therapeutic options of post-COVID-19 related olfactory dysfunction: a systematic review and meta-analysis.

V Asvapoositkul, J Samuthpongtorn, S Aeumjaturapat… - Rhinology, 2022 - europepmc.org
Background Olfactory dysfunction is a typical post-COVID-19 presentation, affecting patients'
quality of life. There are currently multiple treatment options in this group of patients such as …

[PDF][PDF] Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients

LA Vaira, C Hopkins, M Petrocelli, JR Lechien… - …, 2021 - fortbildung.usz.ch
Background: The growing number of COVID-19 patients with long-lasting olfactory disorders
makes it necessary to identify effective treatments that enhance the spontaneous recovery of …

[HTML][HTML] One-year psychophysical evaluation of COVID-19-induced olfactory disorders: a prospective cohort study

EJA Schepens, WM Boek, S Boesveldt, RJ Stokroos… - BMC medicine, 2023 - Springer
Background Olfactory disorders are common in COVID-19. While many patients recover
within weeks, a notable number of patients suffer from prolonged olfactory disorders. Much …

Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view

C Huart, CM Philpott, A Altundag… - International forum of …, 2021 - Wiley Online Library
The frequent association between coronavirus disease 2019 (COVID‐19) and olfactory
dysfunction is creating an unprecedented demand for a treatment of the olfactory loss …

Intranasal corticosteroid treatment on recovery of long‐term olfactory dysfunction due to COVID‐19

M Hosseinpoor, M Kabiri, M Rajati Haghi… - The …, 2022 - Wiley Online Library
Background and Aims Olfactory dysfunction is a recognized manifestation in patients
infected with Coronavirus Disease 2019 (COVID‐19). This investigation aimed to assess the …